Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 160,200 | 103,800 | 262,900 | 212,200 | 163,300 |
| Marketable Securities | 816,500 | 790,800 | 726,400 | 587,200 | 485,000 |
| Receivables | 387,600 | 391,600 | 350,000 | 301,200 | 279,000 |
| Inventories | 31,700 | 33,400 | 35,100 | 37,000 | 29,300 |
| Other current assets | 100,600 | 113,200 | 79,100 | 67,900 | 62,700 |
| TOTAL | $1,496,600 | $1,432,800 | $1,453,500 | $1,205,500 | $1,019,300 |
| Non-Current Assets | |||||
| PPE Net | 65,600 | 62,800 | 58,600 | 60,900 | 66,800 |
| Investments And Advances | 515,600 | 380,300 | 401,500 | 457,500 | 489,000 |
| Intangibles | 36,900 | 37,200 | 37,200 | 0 | 0 |
| Other Non-Current Assets | 498,400 | 446,700 | 417,900 | 419,500 | 430,600 |
| TOTAL | $1,116,500 | $927,000 | $915,200 | $937,900 | $986,400 |
| Total Assets | $2,613,100 | $2,359,800 | $2,368,700 | $2,143,400 | $2,005,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 391,600 | 355,700 | 347,600 | 297,800 | 265,700 |
| Other current liabilities | N/A | 18,400 | 20,700 | 18,100 | 20,000 |
| TOTAL | $582,500 | $374,100 | $537,700 | $485,100 | $285,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 169,500 | N/A | 0 | 169,000 |
| Deferred Revenues | 21,200 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 177,600 | 131,700 | 123,200 | 113,700 | 127,600 |
| TOTAL | $177,600 | $301,200 | $123,200 | $113,700 | $296,600 |
| Total Liabilities | $760,100 | $675,300 | $660,900 | $598,800 | $582,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,652 | 97,575 | 96,588 | 96,134 | 95,639 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -387,900 | -483,400 | -406,800 | -495,800 | -564,300 |
| Other shareholders' equity | -1,100 | -2,700 | -7,900 | -14,000 | -12,200 |
| TOTAL | $1,853,000 | $1,684,500 | $1,707,800 | $1,544,600 | $1,423,400 |
| Total Liabilities And Equity | $2,613,100 | $2,359,800 | $2,368,700 | $2,143,400 | $2,005,700 |